Related Experiment Video
Updated: Jul 12, 2026

Establishment of an Experimental Mouse Model of Endometrioma to Study its Related Infertility
Published on: April 5, 2024
Association Between Endometriosis and Cardiovascular Disease: Insights From the UK Biobank
Clara M Meijs1, Benjamin Gruenberger1, Sanne A E Peters2,3
1Institute of Clinical Epidemiology, Public Health, Health Economics, Medical Statistics and Informatics, Medical University of Innsbruck Innsbruck Austria.
Insights
Women with endometriosis face an 18% higher risk of cardiovascular disease (CVD), particularly coronary heart disease. Hysterectomy may partially explain this link, warranting further research into the connection between endometriosis and heart health.
Area of Science:
- Reproductive Medicine
- Cardiovascular Medicine
- Epidemiology
Background:
- Endometriosis is linked to increased cardiovascular disease (CVD) risk.
- The precise mechanisms underlying this association are not fully understood.
Purpose of the Study:
- To investigate the relationship between endometriosis and CVD risk.
- To explore the role of hysterectomy and oophorectomy in mediating this association.
Main Methods:
- Utilized UK Biobank data from 264,740 women.
- Applied Cox regression analysis, adjusting for multiple risk factors.
- Conducted subgroup and mediation analyses.
Main Results:
- Endometriosis was associated with an 18% increased risk of CVD (HR 1.18), primarily coronary heart disease.
- A 12% lower risk of all-cause mortality was observed in women with endometriosis.
- Hysterectomy emerged as a potential partial mediator in the endometriosis-CVD association.
Conclusions:
- Endometriosis is associated with elevated CVD risk, especially coronary heart disease.
- Hysterectomy may partially mediate the increased CVD risk in endometriosis patients.
- Further research is needed to clarify causal pathways between endometriosis, treatments, and cardiovascular outcomes.
Background:
Endometriosis has been associated with a higher risk of cardiovascular disease (CVD), but the underlying mechanisms remain incompletely understood.
Methods:
Using UK Biobank data, we assessed the relationship between endometriosis and CVD (defined as a composite of fatal and non-fatal coronary heart disease, peripheral artery disease, and stroke), cardiovascular mortality, and all-cause mortality, applying Cox regression analysis while adjusting for conventional and emerging, lifestyle and demographic, and female-specific CVD risk factors. Furthermore, we performed subgroup analysis across age and female-specific factors, and mediation analysis to study the role of hysterectomy and oophorectomy.
Results:
We included 264 740 women without CVD at baseline (median age 57 [25th-75th percentile 50-63] years; 8194 with endometriosis) from the UK Biobank. During 3 484 788 person-years of follow-up, 22 283 women developed CVD. Endometriosis was associated with an 18% higher risk of CVD (hazard ratio 1.18 [95% CI 1.10-1.28]), mainly driven by coronary heart disease (1.24 [1.12-1.37]). Conversely, endometriosis was related to a 12% lower risk of all-cause mortality (0.88 [0.80-0.98]). The association with cardiovascular mortality was not significant (0.85 [0.63-1.13]). Mediation analysis suggested that hysterectomy may partially mediate the association between endometriosis and CVD. Subgroup analyses did not yield significant differences.
Conclusions:
Endometriosis is associated with a higher risk of CVD, especially coronary heart disease. Mediation analysis suggests that hysterectomy partly explains this association. Whether hysterectomy may proxy endometriosis severity instead of being a true mediator remains to be elucidated. These findings highlight the need for studies that unravel the causal mechanisms linking endometriosis, its treatments, and cardiovascular outcomes.
Related Concept Videos
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...
Oogenesis
Coronary Artery Disease I: Introduction
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...